Laura Valerio (L Valerio)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Dna Methylation

Patient Reported Outcomes

Papillary Thyroid

Chronic Myeloid Leukemia

Top Venues

International journal of molecular sciences

Diagnostics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Laura Valerio, Silvia Cantara, Elisa Mattii, Cristina Dalmiglio, Alfonso Sagnella, Antonia Salvemini, Alessandra Cartocci, Fabio Maino, Maria Grazia Castagna
Exploring the Susceptibility to Multiple Primary Tumors in Patients with Differentiated Thyroid Cancer. Diagnostics (Basel, Switzerland) 14 (12) (2024)
Laura Valerio, Silvia Cantara, Elisa Mattii, Cristina Dalmiglio, Alfonso Sagnella, Antonia Salvemini, Alessandra Cartocci, Fabio Maino, Maria Grazia Castagna
Exploring the Susceptibility to Multiple Primary Tumors in Patients with Differentiated Thyroid Cancer. Diagnostics (Basel, Switzerland) 14 (12) (2024)
Laura Valerio, Alessandro Prete, Ferruccio Santini, Laura Agate, Rossella Elisei, Francesco Latrofa
Enlargement of a metastatic lymph node from differentiated thyroid cancer after COVID-19 vaccination. Endocrine (2023)
Laura Valerio, Cristina Dalmiglio, Fabio Maino, Elisa Mattii, Andrea Trimarchi, Alessandra Cartocci, Maria Grazia Castagna
Dynamic Risk Stratification Integrated with ATA Risk System for Predicting Long-Term Outcome in Papillary Thyroid Cancer. Cancers 15 (18) (2023)
Silvia Cantara, Cristina Dalmiglio, Carlotta Marzocchi, Alfonso Sagnella, Lucia Brilli, Andrea Trimarchi, Fabio Maino, Laura Valerio, Maria Grazia Castagna
Pilot Study on the Impact of Polymorphisms Linked to Multi-Kinase Inhibitor Metabolism on Lenvatinib Side Effects in Patients with Advanced Thyroid Cancer. International journal of molecular sciences 24 (6) (2023)
Silvia Cantara, Cristina Dalmiglio, Carlotta Marzocchi, Alfonso Sagnella, Lucia Brilli, Andrea Trimarchi, Fabio Maino, Laura Valerio, Maria Grazia Castagna
Pilot Study on the Impact of Polymorphisms Linked to Multi-Kinase Inhibitor Metabolism on Lenvatinib Side Effects in Patients with Advanced Thyroid Cancer. International journal of molecular sciences 24 (6) (2023)
Laura Valerio, C Giani, A Matrone, B Pontillo-Contillo, E Minaldi, L Agate, E Molinaro, Rossella Elisei
Adrenal insufficiency in thyroid cancer patients treated with tyrosine kinase inhibitors and detected by ACTH stimulation test. Journal of endocrinological investigation (2023)
Silvia Cantara, Cristina Dalmiglio, Carlotta Marzocchi, Alfonso Sagnella, Lucia Brilli, Andrea Trimarchi, Fabio Maino, Laura Valerio, Maria Grazia Castagna
Pilot Study on the Impact of Polymorphisms Linked to Multi-Kinase Inhibitor Metabolism on Lenvatinib Side Effects in Patients with Advanced Thyroid Cancer. International journal of molecular sciences 24 (6) (2023)
Laura Valerio, Federica Guidoccio, Carlotta Giani, Elisa Tardelli, Giulia Puccini, Luciana Puleo, Elisa Minaldi, Giuseppe Boni, Rossella Elisei, Duccio Volterrani
[18F]-FDG-PET/CT Correlates With the Response of Radiorefractory Thyroid Cancer to Lenvatinib and Patient Survival. The Journal of clinical endocrinology and metabolism 106 (8) (2021)